| Шығарылым |
Атауы |
Файл |
| Том 2, № 2 (2025) |
Advancing China’s end tuberculosis strategy goals leveraged by active case
finding and preventive therapy |
(Eng)
|
|
Xu C., Zhao Y.
|
| Том 2, № 1 (2025) |
Ayushman Arogya Mandir: a revolutionary primary healthcare approach shaping India’s path to universal health coverage |
(Eng)
|
|
Patnaik A., Kotwal A., Mangla H., Rai J.
|
| Том 2, № 1 (2025) |
Brazilian legislation on innovation policy: a brief history |
(Eng)
|
|
Gram K., Kritski A., de Oliveira M., Marchini F.
|
| Том 1, № 1 (2024) |
Current challenges and future development of India’s healthcare system’ towards tuberculosis free India – research evidence and programmatic initiatives |
(Eng)
|
|
Gopalan N., Newtonraj A., Elizabeth L.
|
| Том 2, № 2 (2025) |
Development of approaches for evaluating the pharmacokinetics
of meropenem during endolymphatic antibiotic treatment in critically ill
patients |
(Eng)
|
|
Smirnov V., Оrekhov S., Korobov S., Yusuf E., Kharitonov V., Kislenko А., Turenko V., Ramenskaya G., Karimova Z., Esipov А., Pavlov А., Filippov А., Kislenko А., Kharitonov V.
|
| Том 1, № 1 (2024) |
Digital transformation of healthcare in the Russian Federation |
(Eng)
|
|
Gusev A., Vankov V., Artemova O.
|
| Том 1, № 1 (2024) |
Editorial |
(Eng)
|
|
Murashko M., Glybochko P.
|
| Том 2, № 1 (2025) |
From global practice to national strategy: horizon scanning tools for healthcare transformation in Russia |
(Eng)
|
|
Musina N., Fediaeva V., Tarasov V.
|
| Том 2, № 2 (2025) |
Gastrointestinal symptoms and RT-PCR in adults with COVID-19:а post-hoc analysis |
(Eng)
|
|
Wibisono A., Fauzi A., Friska D., Suryoadji K., Surandy A., Muzelina V., Syam A., Sudrajat D., Abdullah M.
|
| Том 1, № 1 (2024) |
Health system strengthening in China: progress, challenges and ways forward |
(Eng)
|
|
Liu X.
|
| Том 2, № 1 (2025) |
Healthy lifestyles of contemporary Chinese population: challenges and new initiatives in primary cancer prevention |
(Eng)
|
|
Wu M., Huang H., Sun P., Qie R., Hu Z., Yan Q., Fu R., Lin Y., Ma X., Zhang Y., He J.
|
| Том 2, № 2 (2025) |
Implementation of artificial intelligence technologies in Russian healthcare:
results of 2018–2024 |
(Eng)
|
|
Murashko M., Vankov V., Artemova O., Gusev A.
|
| Том 2, № 1 (2025) |
Multi-targeted molecular docking, pharmacokinetic analysis, and drug-likeness evaluation of alkaloids for anti-diabetic drug development |
(Eng)
|
|
Meressa A., Girma B., Negassa T., Nigussie G., Kasahun M., Abdisa N., Ashenef S., Taye S., Belitibo D., Animaw Z., Wakene W., Akele B., Endale M.
|
| Том 1, № 1 (2024) |
Profiling the unique passage of South Africa’s health system reforms towards realisation of universal health coverage |
(Eng)
|
|
Moeti T.
|
| Том 1, № 1 (2024) |
Public mental health – the Indian perspective |
(Eng)
|
|
Goel A.
|
| Том 1, № 1 (2024) |
The Brazilian health economic-industrial complex perspective: health as a strategic option for BRICS development |
(Eng)
|
|
de La Roca Soares M., Gadelha C., Kamia F.
|
| Том 2, № 2 (2025) |
The population growth in Egypt: from health perspective challenges to comprehensive solutions |
(Eng)
|
|
Ghaffar K., El Alfy A., El Tayeb M., Rashwan E., Hassany M.
|
| Нәтижелер 17 - 1/17 |
|
